Concepedia

Richard Harrop

RH

Statistics

Publications

39

Citations

3.3K

H-Index

32

Active since

1993

Affiliations

Oxford BioMedica (United Kingdom)(Current)

University of York

The Christie Hospital

Cardiff University

Cancer Research UK

Richard Harrop is an author at Oxford BioMedica (United Kingdom) specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

1993–2020

39

Publications

39

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Stéphane Palfi, Jean Marc Gurruchaga, G. Ralph et al. · The Lancet · 2014 · 432 citations

, , +11

CD4+CD25+FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer

Sarah L. Clarke, Gareth Betts, Andrea Plant et al. · PLoS ONE · 2006 · 216 citations · Full text

Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Robert J. Amato, Robert E. Hawkins, Howard L. Kaufman et al. · Clinical Cancer Research · 2010 · 195 citations · Full text

The schistosome egg: development and secretions

Peter D. Ashton, Richard Harrop, Bhavik A. Shah et al. · Parasitology · 2001 · 180 citations · Full text

Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study

Peter A. Campochiaro, Andreas Lauer, Elliott H. Sohn et al. · Human Gene Therapy · 2016 · 179 citations · Full text

1–5 of 39